Origin Therapeutics Holdings (XCNQ:ORIG) COGS-to-Revenue : 0.00 (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings COGS-to-Revenue?

Origin Therapeutics Holdings's Cost of Goods Sold for the three months ended in Jun. 2023 was C$0.00 Mil. Its Revenue for the three months ended in Jun. 2023 was C$0.00 Mil.

Origin Therapeutics Holdings's COGS to Revenue for the three months ended in Jun. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Origin Therapeutics Holdings's Gross Margin % for the three months ended in Jun. 2023 was N/A%.

Origin Therapeutics Holdings COGS-to-Revenue Historical Data

The historical data trend for Origin Therapeutics Holdings's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings COGS-to-Revenue Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

COGS-to-Revenue

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
COGS-to-Revenue	Get a 7-Day Free Trial				-	-	-	-	-

Origin Therapeutics Holdings COGS-to-Revenue Calculation

Origin Therapeutics Holdings's COGS to Revenue for the fiscal year that ended in Sep. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Origin Therapeutics Holdings's COGS to Revenue for the quarter that ended in Jun. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Origin Therapeutics Holdings (XCNQ:ORIG) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Origin Therapeutics Holdings's Gross Margin % for the three months ended in Jun. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Origin Therapeutics Holdings COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.